BNR vs CCM
Burning Rock Biotech Limited and Concord Medical Services Holdings Ltd., side by side — 8 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BNR | CCM |
|---|---|---|
| Revenue | ¥539.6M | ¥460.5M |
| Net income | ¥-55.3M | ¥-92.8M |
| Gross margin | 74.7% | 5.6% |
| Net margin | −10.3% | −20.2% |
| Return on equity | −9.9% | −195.2% |
| Diluted EPS | — | — |
| Dividend / share | — | ¥0.00 |
| Payout ratio | — | −0.0% |
| Free cash flow | ¥-33.7M | ¥-258.1M |
| Equity | ¥535.3M | ¥-2.1B |
| Net debt / equity | −0.89× | −0.65× |
| Current ratio | 2.99× | 0.48× |
| Revenue CAGR 5y | 4.6% | 15.6% |
| Profit CAGR 5y | — | — |
BNR bills 1.2× the revenue of CCM, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
8 years side by side
| Fiscal year | BNR | CCM |
|---|---|---|
| FY2025 | ¥539.6M | ¥460.5M |
| FY2024 | ¥515.8M | ¥384.0M |
| FY2023 | ¥537.4M | ¥537.4M |
| FY2022 | ¥563.2M | ¥472.1M |
| FY2021 | ¥507.9M | ¥485.6M |
| FY2020 | ¥429.9M | ¥223.0M |
| FY2019 | ¥381.7M | ¥198.4M |
| FY2018 | ¥208.9M | ¥190.9M |
Net income by year
Bottom line
| Fiscal year | BNR | CCM |
|---|---|---|
| FY2025 | ¥-55.3M | ¥-92.8M |
| FY2024 | ¥-346.6M | ¥-308.2M |
| FY2023 | ¥-653.7M | ¥-297.7M |
| FY2022 | ¥-971.2M | ¥-489.7M |
| FY2021 | ¥-796.7M | ¥-271.4M |
| FY2020 | ¥-407.2M | ¥-310.0M |
| FY2019 | ¥-169.2M | ¥-307.0M |
| FY2018 | ¥-177.5M | ¥-234.9M |
Advertisement
AdSense · Rectangle 336×280
The companies